Cargando…

Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?

OBJECTIVE: To evaluate serum anti-Mullerian hormone (AMH) levels in adolescent and young adult (AYA) Turkish patients with Polycystic ovary syndrome (PCOS), and to determine whether it had a diagnostic value. MATERIALS AND METHODS: A total of 90 AYA patients were recruited for this study. The study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokmak, Aytekin, Timur, Hakan, Aksoy, Rıfat Taner, Çınar, Mehmet, Yılmaz, Nafiye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2015
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588471/ https://www.ncbi.nlm.nih.gov/pubmed/28913069 http://dx.doi.org/10.4274/tjod.21549

Ejemplares similares

Role of Versican and ADAMTS-1 in Polycystic Ovary Syndrome
por: Özler, Sibel, et al.
Publicado: (2017)

Does an increased number of cesarean sections result in greater risk for mother and baby in low-risk, late preterm and term deliveries?
por: Hancerliogullari, Necati, et al.
Publicado: (2019)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

The effect of a pre-procedure information video on anxiety levels in patients undergoing hysterosalpingography: A prospective case-control study
por: Erkılınç, Selçuk, et al.
Publicado: (2018)

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022)

Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
por: Dursun, Fatma, et al.
Publicado: (2016)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran, Yu, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
por: Sivanandy, Mala S., et al.
Publicado: (2023)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

Inflammatory Markers in Peripheral Blood Cells Cannot Predict Intrauterine Insemination Outcome: A Retrospective Cohort Study
por: Pekcan, Meryem Kuru, et al.
Publicado: (2021)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Kim, Hye Ok
Publicado: (2013)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate
por: Hestiantoro, Andon, et al.
Publicado: (2016)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
por: Ahmed, Nada, et al.
Publicado: (2019)

Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
por: Mimouni, Nour El Houda, et al.
Publicado: (2021)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

Anti-Műllerian hormone – a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome
por: Neagu, M, et al.
Publicado: (2012)

Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
por: Kohzadi, Mozhgan, et al.
Publicado: (2020)

Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2021)

Evaluation of Serum Human Epididymis Protein 4 Levels in Women with Polycystic Ovary Syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2019)

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
por: Acmaz, G., et al.
Publicado: (2019)

Longitudinal Anti-Müllerian Hormone in Women with Polycystic Ovary Syndrome: An Acupuncture Randomized Clinical Trial
por: Franasiak, Jason, et al.
Publicado: (2012)

Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
por: Dumont, Agathe, et al.
Publicado: (2015)

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
por: Tata, Brooke, et al.
Publicado: (2018)

Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
por: Kollmann, Martina, et al.
Publicado: (2019)

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
por: Du, Juan, et al.
Publicado: (2021)

Impact of laparoscopic ovarian drilling on serum anti-mullerian hormone levels in patients with anovulatory Polycystic Ovarian syndrome
por: Paramu, Sobhana
Publicado: (2016)

Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome
por: Parco, Sergio, et al.
Publicado: (2011)

Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
por: Falbo, Angela, et al.
Publicado: (2010)

Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome
por: Xi, Wenyan, et al.
Publicado: (2016)

Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome
por: Szafarowska, Monika, et al.
Publicado: (2019)

Relationship between seasons and pregnancy rates during intrauterine insemination. A historical cohort
por: Pekcan, Meryem Kuru, et al.
Publicado: (2019)

Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women
por: Tola, Hafza, et al.
Publicado: (2018)

The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
por: Karadeniz, Muammer, et al.
Publicado: (2007)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5d1a3d3jtulj1nlrin64av4i6h